<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess current and long-term associations of glycemia with <z:mp ids='MP_0002959'>microalbuminuria</z:mp>, a marker of generalized endothelial injury </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We measured clinical characteristics, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, and the urinary albumin-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio (UACR) in 1,311 men and 1,518 women attending the sixth examination cycle (1995-1998) of the Framingham Offspring Study </plain></SENT>
<SENT sid="2" pm="."><plain>After excluding participants with <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) at the baseline examination (1971-1974), we used fasting <z:chebi fb="105" ids="17234">glucose</z:chebi> measured at baseline, examination 6, and at least two additional examinations from 1974 to 1995 in regression models to predict risk for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (UACR &gt; or = 30 mg/g) associated with baseline, current, and 24-year time-integrated glycemia </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:mp ids='MP_0002959'>Microalbuminuria</z:mp> was present in 9.5% of men and 13.4% of women </plain></SENT>
<SENT sid="4" pm="."><plain>Among men, age-adjusted odds ratios (95% CI) for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> associated with each 0.28 mmol/l (5 mg/dl) increase in baseline, current, and time-integrated <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were 1.12 (1.00-1.16), 1.08 (1.05-1.10), and 1.16 (1.11-1.21), respectively </plain></SENT>
<SENT sid="5" pm="."><plain>These effects persisted after adjustment for systolic blood pressure and other confounders </plain></SENT>
<SENT sid="6" pm="."><plain>Higher <z:chebi fb="105" ids="17234">glucose</z:chebi> levels also predicted incident <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Mean time-integrated <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were highest among men who developed both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> and <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (SE 6.82 +/- 0.16 mmol/l), intermediate among men with either condition (6.03 +/- 0.65 mmol/l), and lowest among men with neither condition (5.49 +/- 0.02 mmol/l; P &lt; 0.001 for <z:hpo ids='HP_0000001'>all</z:hpo> pairwise comparisons) </plain></SENT>
<SENT sid="8" pm="."><plain>We observed similar associations in women </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Long-term <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> and subdiabetic glycemia increase risk for <z:mp ids='MP_0002959'>microalbuminuria</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain><z:mp ids='MP_0002959'>Microalbuminuria</z:mp>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> seem to arise together over the course of decades, consistent with the hypothesis that they share a common antecedent </plain></SENT>
</text></document>